Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction.
BACKGROUND
Recent results from animal studies suggest that stem cells may be able to home to sites of myocardial injury to assist in tissue regeneration. However, the histological interpretation of postmortem tissue, on which many of these studies are based, has recently been widely debated.


RESULTS
With the use of the high sensitivity of a combined single-photon emission CT (SPECT)/CT scanner, the in vivo trafficking of allogeneic mesenchymal stem cells (MSCs) colabeled with a radiotracer and MR contrast agent to acute myocardial infarction was dynamically determined. Redistribution of the labeled MSCs after intravenous injection from initial localization in the lungs to nontarget organs such as the liver, kidney, and spleen was observed within 24 to 48 hours after injection. Focal and diffuse uptake of MSCs in the infarcted myocardium was already visible in SPECT/CT images in the first 24 hours after injection and persisted until 7 days after injection and was validated by tissue counts of radioactivity. In contrast, MRI was unable to demonstrate targeted cardiac localization of MSCs in part because of the lower sensitivity of MRI.


CONCLUSIONS
Noninvasive radionuclide imaging is well suited to dynamically track the biodistribution and trafficking of mesenchymal stem cells to both target and nontarget organs.
Kraitchman
Dara L
DL
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA. dara@mri.jhu.edu
Tatsumi
Mitsuaki
M
Gilson
Wesley D
WD
Ishimori
Takayoshi
T
Kedziorek
Dorota
D
Walczak
Piotr
P
Segars
W Paul
WP
Chen
Hunter H
HH
Fritzges
Danielle
D
Izbudak
Izlem
I
Young
Randell G
RG
Marcelino
Michelle
M
Pittenger
Mark F
MF
Solaiyappan
Meiyappan
M
Boston
Raymond C
RC
Tsui
Benjamin M W
BM
Wahl
Richard L
RL
Bulte
Jeff W M
JW
D000818:Animals; D002454:Cell Differentiation; D002455:Cell Division; D002470:Cell Survival; D004285:Dogs; D007205:Indium Radioisotopes; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D045164:Mesenchymal Stem Cell Transplantation / Q000009:adverse effects; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000628:therapy*; D009942:Organometallic Compounds; D015125:Oxyquinoline / Q000031:analogs & derivatives; D015203:Reproducibility of Results; D013234:Stem Cells / Q000000981:diagnostic imaging*; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods* / Q000592:standards; D014057:Tomography, X-Ray Computed; D014184:Transplantation, Homologous
D007205:Indium Radioisotopes; D009942:Organometallic Compounds; C032950:indium oxine; D015125:Oxyquinoline